compare suppliers & send inquiries for free
Country of origin
Established in: 2012
MOQ: 1 kg
GMP and ISO14001 certified manufacturing sites
Robust R&D team with 300+ professionals
Modern high-tech pharmaceutical enterprise
Established in: 1865
Valid Regulatory support
Marketing Intelligence to stay on trend and ahead in the market
Tailored value-added services that support the increase of market potential
Established in: 1994
All our 5 plants are top notch and FDA approved
We are a backwards integrated company
We have received 24 CEP’s and 27 USDMF’s
Established in: 1941
Pilot plant & cGMP Kilolab
Human API & Veterinary API EU GMP
API and FDF production, API R&D & CDMO
Established in: 2019
MOQ: 1 kg
Focused on pharmaceutical industry
Reasonable price for the customers
Full service from R&D stage to commercial stage
Established in: 1963
World’s 1st exclusive API distributor
Portfolio of 600+ APIs
>250 clients in Europe
Established in: 2011
MOQ: 1 g
Fast Response and Good Communication
Willingness To Start From Small
Flexible Payment Terms
Replies in a day or 2
How does it work?
You can register for free as long as you are registering on behalf of a legal company related to the pharmaceutical industry
Search in the search bar the product that you’re looking for. We’ll show you an overview of all available suppliers. Use the filters to select the relevant suppliers only
Have you found interesting suppliers? Then it’s time to contact them. Use the send inquiry button and send them a message. You can send for each product, 3 inquiries per week
Suppliers get notified by Pharmaoffer that they’ve received a new inquiry. They will come back to you with their questions, certificates, and offer in the chat on Pharmaoffer. We will send you an email in case of any news
Does the supplier meet your quality and commercial requirements? Then you can place the order. Just follow the steps of our order module
Looking for Mirabegron 223673-61-8?
- Here you will find a list of producers, manufacturers and traders of Mirabegron. You can sort by certificates such as GMP, FDA, CEP, Written Confirmation and more. Send inquiries for free and get in direct contact with the supplier of your choice.
- API | Excipient name:
- Cas Number:
- DrugBank number:
- Unique Ingredient Identifier:
Why are professionals looking for Mirabegron? Mirabegron is a beta-3 adrenergic receptor agonist for the management of overactive bladder. It is an alternative to antimuscarinic drugs for this indication. FDA approved on June 28, 2012.
More information such as the structure, indication or toxicity is available on Drugbank, click the ID above.
Mirabegron is a type of Urological agents
Urological agents are a vital subcategory of pharmaceutical active pharmaceutical ingredients (APIs) used for the treatment of various urological disorders. These agents encompass a wide range of drugs that target the urinary system, including the kidneys, bladder, ureters, and urethra.
One common type of urological agent is the alpha-blockers. These medications work by relaxing the smooth muscles in the prostate gland, bladder neck, and urethra, thereby improving urine flow and relieving symptoms associated with benign prostatic hyperplasia (BPH). Alpha-blockers are frequently prescribed to alleviate urinary retention and reduce the urgency and frequency of urination.
Another important class of urological agents is the antimuscarinics. These drugs act by blocking the action of acetylcholine, a neurotransmitter responsible for the contraction of the bladder muscle. By inhibiting these contractions, antimuscarinics help to reduce overactive bladder symptoms, such as frequent urination, urgency, and urge incontinence.
Additionally, urological agents may include medications for the treatment of urinary tract infections (UTIs), such as antibiotics targeting specific bacteria commonly responsible for UTIs. These antibiotics work by inhibiting bacterial growth and eradicating the infection.
The development of urological agents plays a crucial role in improving the quality of life for patients suffering from urological conditions. These pharmaceutical APIs offer effective therapeutic options to manage symptoms and address the underlying causes of urological disorders. By targeting specific mechanisms within the urinary system, urological agents offer precise and targeted treatment approaches. It is essential for healthcare professionals to stay updated on the latest advancements in urological agents to ensure optimal patient care.
Mirabegron (Urological agents), classified under Genitourinary Agents
Genitourinary agents are a category of pharmaceutical active ingredients (APIs) that are specifically designed to target and treat disorders related to the genitourinary system. The genitourinary system encompasses the organs and structures involved in the production, storage, and elimination of urine, as well as the reproductive organs.
These APIs play a crucial role in the treatment of various genitourinary conditions, including urinary tract infections (UTIs), erectile dysfunction, urinary incontinence, benign prostatic hyperplasia (BPH), and other related disorders. They exert their therapeutic effects by interacting with specific receptors or enzymes in the genitourinary system, regulating physiological processes, and restoring normal function.
Some commonly used genitourinary agents include alpha-blockers, which relax the smooth muscles in the prostate and bladder neck, improving urine flow in patients with BPH. Additionally, phosphodiesterase type 5 inhibitors (PDE5 inhibitors) are widely prescribed for erectile dysfunction, as they enhance blood flow to the penile tissues, facilitating erection.
These APIs are typically formulated into various dosage forms, such as tablets, capsules, creams, gels, or injections, allowing for convenient administration to patients. The development and production of genitourinary agents involve stringent quality control measures and compliance with regulatory guidelines to ensure safety, efficacy, and consistent product performance.
In summary, genitourinary agents form a crucial category of pharmaceutical APIs used to treat a range of disorders affecting the genitourinary system. Their targeted mechanisms of action and diverse dosage forms make them valuable tools in improving genitourinary health and enhancing patients' quality of life.
Mirabegron manufacturers | traders | suppliers
We have 23 companies offering Mirabegron from 7 different countries.
Get in contact with the supplier of your choice:
- Shandong Loncom Pharmaceutical CO.,Ltd. from China
- DKSH from Switzerland
- Vasudha Pharma Chem Ltd. from India
- Saneca Pharma from Slovakia
- Apino Pharma Co., Ltd. from China
- TIEFENBACHER API + Ingredients from Germany
- Shandong Octagon Chemicals Limited from China
- Infar, S.A. from Spain
- Lupin from India
- Zhejiang Hongyuan from China
- Megafine Pharma (P) Ltd. from India
- Cosma from Italy
- Cadila Healthcare from India
- Hangzhou Verychem Sci&Tec Co.Ltd from China
- MSN Labs. from India
- Micro Labs from India
- Jiangxi Synergy from China
- Piramal Pharma Solutions from India
- Glenmark Pharma from India
- ZCL Chemicals from India
- Aurobindo from India
- Hetero Drugs from India
- Dr. Reddy's from India
Let the supplier know whether you are looking for a product with a specific monograph such as EP (Ph. Eur.), USP, JP, BP or another quality. Or, whether you are looking for hydrochloride (HCl), anhydricum, base, micronisatum or a specific purity.
You can use the filters to find high-quality suppliers. For example, you can select GMP, FDA or ISO certified suppliers. Visit our FAQ page or use the chat box in the corner to get more information about Pharmaoffer.